Seized drugs
Expert Algorithm for Substance Identification (EASI)
Developing Aptamer-Based Colorimetric Opioid Tests
Determination of Δ9-THC, THCA, Δ8-THC, and Total Δ9-THC in 53 Smokable Hemp Plant Products by Liquid Chromatography and Photodiode Array Detection
Evidence-Based Evaluation Of The Analytical Schemes In ASTM E2329-17 Standard Practice For Identification Of Seized Drugs For Methamphetamine Samples
Prevalence of Fentanyl and Its Analogues in a Court-Ordered Mandatory Drug Testing Population
Determination of Δ9-THC, THCA, Δ8-THC, and Total Δ9-THC in 53 Smokable Hemp Plant Products by Liquid Chromatography and Photodiode Array Detection
Evidence-Based Evaluation Of The Analytical Schemes In ASTM E2329-17 Standard Practice For Identification Of Seized Drugs For Methamphetamine Samples
New Forensic Methods to Accurately Determine THC in Seized Cannabis
What's Known and Unknown about Marijuana (Part One)
Marijuana poses many challenges for researchers, law enforcement, and policy makers, challenges that fall into two fields: drug chemistry and toxicology. NIJ scientist Dr. Frances Scott joins this episode to explain the complications in drug chemistry and how difficulties defining marijuana lead to backlogs in crime labs around the country. NIJ Communications Assistant Josh Mondoro hosts.
Reading and Resources from NIJ:
Phase II Metabolites of Drugs in Hair: A Potential Solution for Environmental Contamination
Superhydrophobic Surface Modification of Polymer Microneedles Enables Fabrication of Multimodal Surface-Enhanced Raman Spectroscopy and Mass Spectrometry Substrates for Synthetic Drug Detection in Blood Plasma
The Cross-Reactivity of Cannabinoid Analogs (Delta-8-THC, Delta-10-THC and CBD), Their Metabolites and Chiral Carboxy HHC Metabolites in Urine of Six Commercially Available Homogeneous Immunoassays
A Data-Informed Response to Emerging Drugs
A Data-Informed Response to Emerging Drugs
The emerging drug crisis in the U.S. touches both criminal justice and public health, and experts from both fields came together at NIJ’s 2023 National Research Conference to discuss strategies and tools to fight this problem. Dr. Frances Scott, NIJ scientist and program manager, continues the conference discussion with two fellow panelists: Ciena Bayard, the Method Development and Validation Program Manager for D.C. Office of the Chief Medical Examiner, and Haley Greene, the Deputy Epidemiologist for the Central Region for the Virginia Department of Health. Read the transcript.